ECM
GSK icon

Endurant Capital Management’s GSK GSK Stock Holding History

Endurant Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,800
Closed -$1.88M – 93
2017
Q2 		$1.88M Sell
34,800
-70,560
-67% -$3.76M 0.53% 47
2017
Q1 		$5.55M Buy
105,360
+36,240
+52% +$1.84M 1.79% 22
2016
Q4 		$3.33M Buy
+69,120
New +$3.41M 1.37% 29

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Endurant Capital Management's GSK Position: Q3 2017 in Review

Endurant Capital Management sold out of GSK (GSK) in Q3 2017, closing a stake of 34,800 shares — an estimated $1.88M sold.

Endurant Capital Management first reported a position in GSK in Q4 2016 and held it in 3 quarters. The position peaked at $5.55M in Q1 2017. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2017.

  • Endurant Capital Management reported no remaining GSK position as of Q3 2017 after selling out during the quarter.
  • Endurant Capital Management sold 34,800 GSK shares in Q3 2017, an estimated $1.88M.
  • Endurant Capital Management first reported a position in GSK in Q4 2016 and held it in 3 quarters.
  • Endurant Capital Management's GSK position peaked at $5.55M in Q1 2017.
  • 742 funds tracked by Wall St. Rank held GSK as of Q3 2017.

Based on Endurant Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.